January 2, 2021
Kristin Cahill, who is taking the reins as CEO of GCI Health in January, talks with Doug Simon about how things have changed in the pharmaceutical industry in 2020—and about what healthcare communicators should expect in 2021—in the latest “PR’s Top Pros Talk” video interview.
According to Cahill, pharma’s reputation has risen in the wake of COVID-19, with 40 percent of consumers viewing the industry more favorably since the beginning of the pandemic.
She says that rise in reputation creates an “incredible opportunity for our clients and 0ur colleagues to show up differently,” allowing them “to capitalize on the fact that people are looking to the healthcare industry for science and solutions.”
Cahill outlines a couple of ways in which communicators can make that opportunity work for them. One of those is to “make sure that you’re putting scientific solutions front and center.”
Another is for companies to “put different types of ambassadors and champions to work for companies.” For example, she says they should “think about putting forward everyday researchers and people who are in the thick of it, working every day.”
You can listen to the full podcast here.